Basics G1 Therapeutics, Inc. IPO Date: May 17, 2017 Sector: Healthcare Industry: Biotech Activated in VL: False Average Daily Range Avg Daily Range: $0.54 | 3.43% Avg Daily Range (30 D): $0.00 | 0.00% Avg Daily Range (90 D): $0.01 | 0.20% Institutional Daily Volume Avg Daily Volume: .68M Avg Daily Volume (30 D): M Avg Daily Volume (90 D): .22M Trade Size Avg Trade Size (Sh.): 129 Avg Trade Size (Sh.) (30 D): 0 Avg Trade Size (Sh.) (90 D): 381 Institutional Trades Total Inst.Trades: 1,489 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.95M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $.77M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 111.87K         News Sep 18, 2024 @ 12:54 PM Pharmacosmos Group and G1 Therapeutics Announce Su... Source: Globe Newswire Aug 15, 2024 @ 2:55 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: N/A Jul 1, 2024 @ 12:00 PM G1 Therapeutics Added to the Russell 2000® and ... Source: G1 Therapeutics Jun 30, 2024 @ 1:10 PM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Jun 25, 2024 @ 11:27 AM Ball To Rally More Than 23%? Here Are 10 Top Analy... Source: Avi Kapoor Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.86 $-.1 $-.2 Diluted EPS $-.86 $-.1 $-.2 Revenue $ 58.2M $ 16.55M $ 14.48M Gross Profit $ $ $ Net Income / Loss $ -44.77M $ -5.47M $ -10.22M Operating Income / Loss $ -37.88M $ -3.54M $ -9.05M Cost of Revenue $ $ $ Net Cash Flow $ -40.9M $ -4.81M $ -12.33M PE Ratio